Next Article in Journal
Parks and the Pandemic: A Scoping Review of Research on Green Infrastructure Use and Health Outcomes during COVID-19
Next Article in Special Issue
Longitudinal Associations of Substance Use Risk Profiles with the Use of Alternative Tobacco Products and Conventional Smoking among Adolescents
Previous Article in Journal
Experience of Vulnerable Women Narrated through the Body-Mapping Technique
Previous Article in Special Issue
Perceived Change in Tobacco Use and Its Associated Factors among Older Adults Residing in Rohingya Refugee Camps during the COVID-19 Pandemic in Bangladesh
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Trends in Exclusive, Dual and Polytobacco Use among U.S. Adults, 2014–2019: Results from Two Nationally Representative Surveys

by
Delvon T. Mattingly
1,*,†,
Luis Zavala-Arciniega
1,†,
Jana L. Hirschtick
1,
Rafael Meza
1,
David T. Levy
2 and
Nancy L. Fleischer
1
1
Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA
2
School of Medicine, Georgetown University, Washington, DC 20057, USA
*
Author to whom correspondence should be addressed.
These authors contribute equally to this work.
Int. J. Environ. Res. Public Health 2021, 18(24), 13092; https://doi.org/10.3390/ijerph182413092
Submission received: 16 November 2021 / Revised: 3 December 2021 / Accepted: 9 December 2021 / Published: 11 December 2021
(This article belongs to the Special Issue Emerging Trends in Combustible Tobacco and Vaping Product Use)

Abstract

:
Although increases in the variety of tobacco products available to consumers have led to investigations of dual/polytobacco use patterns, few studies have documented trends in these patterns over time. We used data from the 2014/2015 and 2018/2019 Tobacco Use Supplement to the Current Population Survey (TUS-CPS) and the 2015–2019 National Health Interview Survey (NHIS) to estimate trends in the following use patterns: exclusive use of cigarettes, electronic nicotine delivery systems (ENDS), other combustibles (cigars/cigarillos/little filtered cigars and traditional pipes/hookah), and smokeless tobacco (four categories); dual use (two product groups) of each product group with cigarettes (three categories); polyuse with cigarettes (all four product groups; one category); and dual/polyuse without cigarettes (one category). We estimated trends in product use patterns overall and by age, sex, and race/ethnicity using two-sample tests for differences in linear proportions. From 2014/2015 to 2018/2019, exclusive ENDS use increased, whereas cigarettes and ENDS dual use decreased. Furthermore, polyuse with cigarettes decreased, whereas dual/polyuse without cigarettes increased, with trends varying by age, sex, and race/ethnicity. Our findings suggest that patterns of dual/polyuse with and without cigarettes have changed in recent years, indicating the need for further surveillance of concurrent tobacco product use patterns.

1. Introduction

Tobacco use is the leading cause of preventable death in the United States (USA) [1]. The tobacco industry is continuing to introduce new products to the market; therefore, the impact on population health remains a significant concern [1,2]. Monitoring tobacco product use, including dual use (use of two tobacco products) and polyuse (use of three or more tobacco products), is critical to gauge trends in product use patterns and project the health consequences of these trends [3].
Research on patterns of multiple tobacco product use in U.S. adults has increased over the past decade [4,5]. In a systematic review of dual use and polyuse, eleven studies have presented prevalence estimates of dual use, and six studies have presented estimates of polyuse from 1992 to 2018 using data from nationally representative studies [5]. This review found that dual use and polyuse are becoming more common throughout the world, and that definitions of dual use and polyuse use have varied over time. Dual/polyuse is also higher among younger adults compared to older adults in the United States [5,6]. In addition, results from a recent study analyzing three nationally representative surveys for the years 2014–2016 reported that the most common adult dual use and polyuse groups in the United States were cigarettes and electronic nicotine delivery systems (ENDS) dual use (1.3–1.8%), and cigarettes, ENDS, and other combustibles (OC, i.e., cigars/cigarillos/little filtered cigars and traditional pipe/hookah) polyuse (0.2–0.7%) [4].
Although dual use and polyuse trends may not be clear in recent years in the United States, trends in individual tobacco product use among adult populations are well documented. For example, studies have shown that cigarette use prevalence is decreasing among youth [7] and adults [8,9]. Furthermore, results from a nationally representative survey suggest that adult ENDS use may be increasing over time, particularly among young adults [10,11], corroborating prior research that found rapid growth in ENDS use in the early 2010s [12]. One study using data from the National Health Interview Survey (NHIS) reported that the contemporary prevalence of cigar use remained relatively stable from 2005 to 2015 (2.3%) [13], although another study using data from the National Surveys on Drug Use and Health (NSDUH) reported that contemporary prevalence of cigar use decreased from 2002 (7.9%) to 2016 (6.3%) [14]. Studies using the Tobacco Use Supplement to the Current Population Survey (TUS-CPS) and the NSDUH reported that adult smokeless tobacco use (SLT) prevalence has changed little in recent years [15,16].
Many studies that have explored dual use or polyuse trends did not include a broad range of tobacco products, instead examining the dual use of cigarettes and e-cigarettes [17,18,19], dual use of cigarettes and cigars or SLT [20,21], or polyuse without ENDS [22]. Moreover, studies have not characterized trends by sociodemographic group, precluding the identification of those most susceptible to the consequences of using multiple tobacco products, including a higher frequency of use, lower likelihood of quitting, and higher risk of both nicotine dependence and poor health outcomes than exclusive tobacco use [23,24,25]. Tobacco use patterns are evolving rapidly; therefore, further investigation using more recent data is needed. This study examined trends in exclusive, dual, and polyuse overall and by age, sex, and race/ethnicity, using 2014–2019 data from two nationally representative U.S. surveys: NHIS, a survey used to examine health trends in the United States, and TUS-CPS, the largest survey on tobacco product use in the United States.

2. Materials and Methods

2.1. Design

We analyzed data from the 2014/2015 and 2018/2019 TUS-CPS and 2015–2019 annual NHIS obtained from the Integrated Public Use Microdata Series (IPUMS) [26].
TUS-CPS is a cross-sectional survey of tobacco use behaviors among adult respondents or proxies aged 18 years or older administered every 3–4 years by the U.S. Census Bureau. The 2014/2015 TUS-CPS included three samples collected in July 2014, January 2015, and May 2015, whereas the 2018/2019 TUS-CPS included three samples collected in July 2018, January 2019, and May 2019. TUS-CPS participants complete the survey using computer-assisted telephone interviewing (CATI) (about two-thirds of the sample) or computer-assisted personal interviewing (CAPI). Response rates in 2014/2015 and 2018/2019 were 54.1% and 56.2%, respectively [27,28]. TUS-CPS is designed to be representative of the U.S. state and national non-institutionalized, civilian adult population, and employs a complex multistage sampling design. Further information on the 2014/2015 and 2018/2019 TUS-CPS waves is publicly available [29]. We restricted our analyses to self-respondents because previous research has shown that the inclusion of proxy respondents may result in underestimation of the prevalence of tobacco use [30].
NHIS is an annual cross-sectional survey designed by the Centers for Disease Control and Prevention’s National Center for Health Statistics to collect information on health status and behaviors, including tobacco use, from U.S. adults aged 18 years or older. Data are collected via personal household interviews using CAPI. Response rates in 2015, 2016, 2017, 2018, and 2019 were 55.2%, 54.3%, 53.0%, 53.1%, and 59.1%, respectively [31,32,33,34,35]. NHIS is designed to be nationally representative of the U.S. non-institutionalized, civilian adult population and employs a complex multistage sampling design. Further details on the methodology of NHIS are published online [36]. We did not include the 2014 NHIS because respondents were not asked questions about the frequency (every day or some days) of cigar/cigarillos/little filtered cigar and traditional pipe use.
Pooling data resulted in a sample of 288,361 adults aged 18 years and over in TUS-CPS (2014/2015 = 157,535 and 2018/2019 = 130,826) and 150,856 adults aged 18 years and over in NHIS (2015 = 33,672, 2016 = 33,028, 2017 = 26,742, 2018 = 25,417, 2019 = 31,997). After excluding missing values for tobacco use variables (TUS = 1.6%, NHIS = 2.1%) and covariates (TUS-CPS = 0.0%, NHIS = 0.4%), the final analytic samples consisted of 283,825 respondents in TUS-CPS and 147,649 respondents in NHIS.

2.2. Measures

2.2.1. Tobacco Product Use

We defined four groups of exclusive tobacco product use: (1) cigarette use, (2) ENDS use, (3) OC use, and (4) SLT use. We defined cigarette use as those who had smoked at least 100 cigarettes in their lifetime and now smoked every day or some days. ENDS, OC, and SLT use were defined based only on everyday or some day use. The OC category included the use of cigars/cigarillos/little filtered cigars and traditional pipe/hookah.
In addition to the four exclusive tobacco product use groups, we also defined five dual use and polyuse groups: (1) cigarettes and ENDS, (2) cigarettes and OC, (3) cigarettes and SLT, (4) polyuse with cigarettes (i.e., cigarettes, ENDS, and OC; cigarettes, ENDS, and SLT; cigarettes, OC, and SLT; all four tobacco product groups), and (5) dual/polyuse without cigarettes (i.e., ENDS and OC; ENDS and SLT; OC and SLT; ENDS, OC, and SLT). The nine tobacco use categories were mutually exclusive.

2.2.2. Covariates

We included the following covariates: sex (female, male); age (18–24 years, 25–34 years, 35–54 years, and 55 years or older); race/ethnicity (Hispanic, Non-Hispanic (NH) White, NH Black, another race/ethnicity). The other race/ethnicity group included NH American Indian/Alaska Native, NH Asian/other Pacific Islander, and NH Multiracial adults in NHIS, and American Indian/Alaska Native, Asian Only, Hawaiian/Pacific Island Only and NH Multiracial groups in TUS-CPS. Supplementary Table S1 displays the prevalence of each covariate by year for TUS-CPS and NHIS from 2014/2015 to 2018/2019.

2.3. Statistical Analyses

We estimated the prevalence and trends for use of any tobacco product, the four exclusive tobacco use outcomes, and the five dual use/polyuse outcomes overall and by age, sex, and race/ethnicity. First, we estimated the prevalence and 95% confidence intervals (CI) for each outcome and stratified them by each covariate. Second, we conducted two-sample tests for linear differences in proportions overall and by each covariate to determine the changes in crude prevalence estimates between 2014/2015 and 2018/2019 for TUS-CPS and between 2015 and 2019 for NHIS using the lincom command in Stata. In all analyses, we used sampling weights to account for the complex survey designs and survey specific methods for variance calculation. Specifically, for TUS-CPS, we used balanced repeated replication with replicate weights, with Fay’s adjustment set to 0.4 [37]. For NHIS, we used Taylor series linearization [38]. We conducted all analyses using Stata 16.1 [39].

3. Results

3.1. Change in Prevalence of Any, Exclusive, Dual and Polytobacco Use over Time

The prevalence of exclusive ENDS use increased from 0.68% in 2014/2015 to 1.22% in 2018/2019 in TUS-CPS and from 1.26% in 2015 to 2.35% in 2019 in NHIS (Table 1). Dual use of cigarettes + ENDS decreased in both TUS-CPS (1.33% to 0.74%) and NHIS (1.62% to 1.25%). Many of the tobacco product use outcomes trended in the same direction in TUS-CPS and NHIS. However, more statistically significant changes over time were observed in TUS-CPS than in NHIS, likely due to sample size limitations in NHIS. For example, the prevalence of exclusive cigarette use, dual use of cigarettes + SLT, and polyuse with cigarettes decreased in TUS-CPS but did not statistically significantly decrease in NHIS over time. In addition, dual/polyuse without cigarettes statistically significantly increased in NHIS (0.37% to 0.63%) but not TUS-CPS (0.25% to 0.29%). Figure S1 visualizes the trends in prevalence of any, exclusive, dual, and polytobacco use over time by survey. We display trends in all tobacco product use outcomes overall and by age, sex, and race/ethnicity for NHIS years 2015, 2016, 2017, 2018, and 2019 in Tables S2–S8.

3.2. Changes in the Prevalence of Any and Exclusive Tobacco Use over Time by Age

From 2014/2015 to 2018/2019, use of any tobacco product decreased among respondents aged 18–24 (18.53% to 13.86%), 25–34 (20.52% to 17.55%), and 35–54 (19.14% to 17.04%) in TUS-CPS and 18–24 (21.47% to 18.13%) in NHIS (Table 2). Exclusive cigarette use also decreased among the same age groups in both surveys, whereas exclusive OC use and exclusive SLT use decreased among respondents aged 18–24. Exclusive ENDS use increased among all age groups in TUS-CPS and respondents aged 18–24, 25–34, and 35–54 in NHIS. For example, among respondents aged 18–24, exclusive ENDS use increased from 1.12% to 3.29 in TUS-CPS and 2.39% to 5.46% in NHIS.

3.3. Changes in the Prevalence of Dual and Polytobacco Use over Time by Age

Dual use of cigarettes + ENDS decreased among all age groups in TUS-CPS and among respondents aged 35–54 and 55+ in NHIS from 2014/2015 to 2018/2019. However, this use pattern increased among respondents aged 25–34 in NHIS (1.48% to 2.19%) (Table 3). Dual use of cigarettes + OC decreased in TUS-CPS among respondents aged 18–24 (1.36% to 0.44%) and 25–34 (1.05% to 0.72%). In addition, dual use of cigarettes + SLT decreased in NHIS among respondents aged 18–24 (0.84% to 0.19%). Polyuse with cigarettes decreased among respondents aged 25–34, 35–54, and 55+ in TUS-CPS, whereas dual/polyuse without cigarettes increased in TUS-CPS among respondents aged 35–54, and among NHIS respondents aged 18–24 and 25–34.

3.4. Changes in the Prevalence of Any and Exclusive Tobacco Use over Time by Sex

From 2014/2015 to 2018/2019, the use of any tobacco product decreased among females (13.21% to 11.47%) and males (21.65% to 19.31%) in TUS-CPS but not NHIS (Table 4). Exclusive use of cigarettes, OC, and SLT decreased among males, and exclusive cigarette use decreased among females in TUS-CPS. Exclusive ENDS use increased among females and males in TUS-CPS (0.54% to 1.02% and 0.82% to 1.45%, respectively) and NHIS (0.89% to 1.93% and 1.66% and 2.81%, respectively).

3.5. Changes in the Prevalence of Dual and Polytobacco Use over Time by Sex

Dual use of cigarettes + ENDS decreased among females in TUS-CPS (1.40% to 0.67%) and males in TUS-CPS (1.24% to 0.81%) and NHIS (1.73% to 1.27%) from 2014/2015 to 2018/2019 (Table 5). Dual use of cigarettes + OC (1.27% to 0.95%) and cigarettes + SLT (0.43% to 0.35%) decreased among males in TUS-CPS. Polyuse with cigarettes decreased among females (0.14% to 0.07%) and males (0.50% and 0.37%) in TUS-CPS, whereas dual/polyuse without cigarettes increased among males in NHIS (0.68% to 1.10%).

3.6. Changes in the Prevalence of Any and Exclusive Tobacco Use over Time by Race/Ethnicity

From 2014/2015 to 2018/2019, the use of any tobacco product decreased among all racial/ethnic groups in TUS-CPS and increased among respondents who identified as another race/ethnicity in NHIS (11.78% to 16.31%) (Table 6). Exclusive cigarette use decreased among all racial/ethnic groups in TUS-CPS and among Hispanic respondents in NHIS. However, exclusive ENDS use increased among all racial/ethnic groups in both surveys except for NH Blacks in TUS-CPS. Exclusive OC (1.81% to 1.59%) and exclusive SLT (1.60% to 1.47%) decreased among NH White respondents in TUS-CPS. In NHIS, exclusive SLT use increased among respondents who identify as another race/ethnicity (0.29% to 1.12%).

3.7. Changes in the Prevalence of Dual and Polytobacco Use over Time by Race/Ethnicity

Dual use of cigarettes + ENDS decreased among NH Black, Hispanic, and respondents of other races/ethnicities in TUS-CPS and NH White respondents in NHIS from 2014/2015 to 2018/2019 (Table 7). Dual use of cigarettes + OC decreased among NH White (0.71% to 0.44%) and NH Black (0.76% to 0.58%) respondents in TUS-CPS and NH Black respondents in NHIS (2.37% to 1.26%). However, in NHIS, dual use of cigarettes + OC increased among another race/ethnicity (0.39% to 0.93%) and Hispanic (0.49% to 0.90%) respondents. Dual use of cigarettes + SLT decreased among Hispanic respondents and polyuse with cigarettes decreased among NH Black respondents in TUS-CPS. Furthermore, dual/polyuse without cigarettes increased among Hispanic respondents in TUS-CPS and NH White, NH Black, and respondents of other race/ethnicities in NHIS.

4. Discussion

Our study examined recent trends in exclusive, dual, and polyuse among U.S. adults using two nationally representative surveys with comparable time points. We observed that patterns of exclusive, dual, and polyuse are changing over time in the U.S. adult population. In addition, variations in trends over time by age, sex, and race/ethnicity suggest that the future monitoring of trends in tobacco product use are needed to address disparities. Decreases in cigarette smoking across groups and increases in ENDS use in some sociodemographic groups have had a major influence on these trends. To the best of our knowledge, our study is among the first to characterize and compare trends in exclusive tobacco use, dual use, and polyuse patterns in separate, nationally representative U.S. adult samples, because most recent investigations have focused on youth [40,41].
We found an increasing trend in exclusive ENDS use and a decreasing trend in the dual use of cigarettes and ENDS in both surveys during the study period. These findings suggest that patterns of ENDS use are changing. In 2014/2015, most ENDS users were dual users with cigarettes, whereas in 2018/2019, most ENDS users were exclusive users. One possible explanation is that the dual use of cigarettes and ENDS could be a transitory stage towards cigarette cessation for some smokers [42]. Moreover, previous studies have reported that young adults are initiating tobacco product use with ENDS over other products, which could also explain the increase in exclusive ENDS use [43,44]. Nationally representative longitudinal studies are necessary to evaluate transitions from dual use involving ENDS to exclusive ENDS use, and vice versa, to understand these relationships more clearly [45].
Our study found that although overall cigarette use has decreased, there are discrepancies in the trends of exclusive cigarette use by survey; exclusive cigarette use statistically significantly decreased over time in TUS-CPS but not in NHIS. To some extent, inter-survey differences may be explained by differences in statistical power, because TUS-CPS has a larger sample than NHIS. In addition, TUS-CPS estimates variance by using the balanced repeated replication method, which produces smaller standard errors and narrower confidence intervals, and which may lead to more precise findings than in NHIS, which uses Taylor linearization series [37,38]. Given the larger sample of TUS-CPS, and the overall decreases in smoking in the United States, it is likely that exclusive cigarette smoking is indeed decreasing, as suggested by TUS-CPS [1]. Our findings demonstrate that most dual use and polyuse groups including cigarettes are also decreasing. Previous studies examining tobacco use trends have described cigarette use overall and not stratified it into exclusive, dual, and poly-cigarette users [8,9]. Our analyses can help capture changes in patterns of cigarette smoking and tobacco product use over time more granularly, especially in the context of using multiple tobacco products.
In some cases, we observed variations in trends between surveys. For example, dual/polyuse without cigarettes increased in NHIS but not TUS-CPS. Additionally, dual use and polyuse with cigarette groups decreased in TUS-CPS but not NHIS, possibly due to statistical power issues. Survey modality might additionally explain differences in results between TUS-CPS and NHIS. In TUS-CPS, more than 60% of respondents answered surveys via telephone interviews [27,28], whereas all respondents in NHIS answered surveys via in-person interviews [31,32,33,34,35]. Research has indicated that some populations might under-report their smoking status over the phone, possibly making it more difficult to compare results between surveys with different methodologies [30]. Another possible explanation is the ways in which tobacco use questions were asked between surveys. For example, respondents in TUS-CPS were asked about whether they smoked traditional pipes and hookah separately, whereas respondents in NHIS were asked about whether they smoked pipes and hookah in one question. However, these minor differences likely did not affect our estimates, given that we examined the use of cigars/cigarillos/little filtered cigars and traditional pipe/hookah as one group. Despite minor methodological differences between surveys, a more thorough investigation of inter-survey variations is needed to better understand these differences in findings. Future research aimed at understanding the impact of using different survey methodologies to estimate the prevalence of dual and polytobacco use may benefit tobacco control researchers and policymakers.
Our study comes with limitations. Sample sizes, especially in NHIS, precluded our ability to examine more granular tobacco product use combinations. Collapsing dual use and polyuse groups into those with and without cigarettes was performed to differentiate tobacco users who use cigarettes from those who do not, under the assumption that health effects differ between these groups. Nevertheless, future studies should attempt to disaggregate these categories to better understand trends in specific dual use and polyuse groups. Our analysis used repeated cross-sectional data to understand population-level trends in prevalence; examining transitions in tobacco product use for individuals requires longitudinal studies that ask about the use of multiple tobacco products over time. Despite these limitations, our study is one of the first to characterize population-level prevalence and trends in exclusive, dual, and polytobacco use among U.S. adults using data from two nationally representative surveys.

5. Conclusions

Our findings demonstrate that exclusive ENDS use increased over time, whereas the dual use of cigarettes and ENDS decreased over time in two nationally representative surveys. Results also suggest that polyuse with cigarettes is decreasing over time, whereas dual/polyuse without cigarettes is increasing. These findings from two nationally representative surveys show how patterns of exclusive, dual, and polyuse are changing rapidly in the current complex context of widely available tobacco products, with variation in trends by age, sex, and race/ethnicity. Continued monitoring of dual use and polyuse is needed to better contextualize population-level use patterns, differences in use patterns by key sociodemographic groups, and inform prevention and cessation efforts that address the use of multiple tobacco products.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/ijerph182413092/s1, Figure S1: Population prevalence of exclusive, dual and polytobacco use among U.S. adults from 2014/2015 to 2018/2019, Table S1: Sample characteristics for the Tobacco Use Supplement to the Current Population Survey (TUS-CPS) and the National Health Interview Survey (NHIS), 2014/2015–2018/2019, Table S2: Population prevalence of exclusive, dual and polytobacco use among U.S. adults from 2015 to 2019 in NHIS, Table S3: Population prevalence of any and exclusive tobacco use among U.S. adults from 2015 to 2019 by age group in NHIS, Table S4: Population prevalence of exclusive, dual and polytobacco use among U.S. adults from 2015 to 2019 by age group in NHIS, Table S5: Population prevalence of any and exclusive tobacco use among U.S. adults from 2015 to 2019 by sex in NHIS, Table S6: Population prevalence of exclusive, dual and polytobacco use among U.S. adults from 2015 to 2019 by sex in NHIS, Table S7: Population prevalence of any and exclusive tobacco use among U.S. adults from 2015 to 2019 by race/ethnicity in NHIS, Table S8: Population prevalence of exclusive, dual and polytobacco use among U.S. adults from 2015 to 2019 by race/ethnicity in NHIS.

Author Contributions

Conceptualization, N.L.F.; methodology, N.L.F.; formal analysis, D.T.M. and L.Z.-A.; writing—original draft preparation, D.T.M. and L.Z.-A.; writing—review and editing, D.T.M., L.Z.-A., J.L.H., R.M., D.T.L. and N.L.F.; visualization, D.T.M. and L.Z.-A.; supervision, N.L.F.; project administration, N.L.F.; funding acquisition, R.M., D.T.L. and N.L.F. All authors have read and agreed to the published version of the manuscript.

Funding

The research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health (NIH) and FDA Center for Tobacco Products (CTP) under Award Number U54CA229974. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration.

Institutional Review Board Statement

This study was deemed not regulated as human subjects research by the University of Michigan Institutional Review Board (HUM00153979 approved 12 December 2018).

Informed Consent Statement

This study used publicly available data and did not involve interaction with human subjects. Informed consent was obtained from all subjects involved in the Tobacco Use Supplement to the Current Population Survey (TUS-CPS) and the National Health Interview Survey (NHIS).

Data Availability Statement

Publicly available datasets were analyzed in this study. TUS-CPS data presented in this study are openly available by the NIH Division of Cancer Control & Population Sciences at https://cancercontrol.cancer.gov/brp/tcrb/tus-cps, accessed on 16 November 2021 and NHIS data are available by the CDC at https://www.cdc.gov/nchs/nhis/index.htm, accessed on 16 November 2021 or by IPUMS at https://nhis.ipums.org/nhis/, accessed on 16 November 2021.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General; U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Atlanta, GA, USA, 2014.
  2. Bhatnagar, A.; Whitsel, L.P.; Blaha, M.J.; Huffman, M.D.; Krishan-Sarin, S.; Maa, J.; Rigotti, N.; Robertson, R.M.; Warner, J.J. New and Emerging Tobacco Products and the Nicotine Endgame: The Role of Robust Regulation and Comprehensive Tobacco Control and Prevention: A Presidential Advisory From the American Heart Association. Circulation 2019, 139, e937–e958. [Google Scholar] [CrossRef] [PubMed]
  3. Pacek, L.R.; Wiley, J.L.; McClernon, F.J. A Conceptual Framework for Understanding Multiple Tobacco Product Use and the Impact of Regulatory Action. Nicotine Tob. Res. 2019, 21, 268–277. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Hirschtick, J.L.; Mattingly, D.T.; Cho, B.; Arciniega, L.Z.; Levy, D.T.; Sanchez-Romero, L.M.; Jeon, J.; Land, S.R.; Mistry, R.; Meza, R.; et al. Exclusive, Dual, and Polytobacco Use Among US Adults by Sociodemographic Factors: Results From 3 Nationally Representative Surveys. Am. J. Health Promot. 2020, 35, 377–387. [Google Scholar] [CrossRef] [PubMed]
  5. Chen, D.T.; Girvalaki, C.; Mechili, E.A.; Millett, C.; Filippidis, F.T. Global Patterns and Prevalence of Dual and Poly-Tobacco Use: A Systematic Review. Nicotine Tob. Res. 2021, 23, 1816–1820. [Google Scholar] [CrossRef]
  6. Kasza, K.A.; Ambrose, B.K.; Conway, K.P.; Borek, N.; Taylor, K.; Goniewicz, M.L.; Cummings, K.M.; Sharma, E.; Pearson, J.L.; Green, V.R.; et al. Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014. N. Engl. J. Med. 2017, 376, 342–353. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Meza, R.; Jimenez-Mendoza, E.; Levy, D.T. Trends in Tobacco Use Among Adolescents by Grade, Sex, and Race, 1991–2019. JAMA Netw. Open 2020, 3, e2027465. [Google Scholar] [CrossRef]
  8. Mattingly, D.T.; Hirschtick, J.L.; Meza, R.; Fleischer, N.L. Trends in prevalence and sociodemographic and geographic patterns of current menthol cigarette use among U.S. adults, 2005–2015. Prev. Med. Rep. 2020, 20, 101227. [Google Scholar] [CrossRef]
  9. Delnevo, C.D.; Giovenco, D.P.; Villanti, A.C. Assessment of Menthol and Nonmenthol Cigarette Consumption in the US, 2000 to 2018. JAMA Netw. Open 2020, 3, e2013601. [Google Scholar] [CrossRef]
  10. Obisesan, O.H.; Osei, A.D.; Uddin, S.M.I.; Dzaye, O.; Mirbolouk, M.; Stokes, A.; Blaha, M.J. Trends in e-Cigarette Use in Adults in the United States, 2016-2018. JAMA Intern. Med. 2020, 180, 1394–1398. [Google Scholar] [CrossRef]
  11. Levy, D.T.; Yuan, Z.; Li, Y.; Mays, D.; Sanchez-Romero, L.M. An Examination of the Variation in Estimates of E-Cigarette Prevalence among U.S. Adults. Int. J. Environ. Res. Public Health 2019, 16, 3164. [Google Scholar] [CrossRef] [Green Version]
  12. McMillen, R.C.; Gottlieb, M.A.; Shaefer, R.M.; Winickoff, J.P.; Klein, J.D. Trends in Electronic Cigarette Use Among U.S. Adults: Use is Increasing in Both Smokers and Nonsmokers. Nicotine Tob. Res. 2015, 17, 1195–1202. [Google Scholar] [CrossRef]
  13. Rostron, B.L.; Corey, C.G.; Gindi, R.M. Cigar smoking prevalence and morbidity among US adults, 2000-2015. Prev. Med. Rep. 2019, 14, 100821. [Google Scholar] [CrossRef] [PubMed]
  14. Weinberger, A.H.; Delnevo, C.D.; Zhu, J.; Gbedemah, M.; Lee, J.; Cruz, L.N.; Kashan, R.S.; Goodwin, R.D. Trends in Cigar Use in the United States, 2002-2016: Diverging Trends by Race/Ethnicity. Nicotine Tob. Res. 2020, 22, 583–587. [Google Scholar] [CrossRef] [PubMed]
  15. Chang, J.T.; Levy, D.T.; Meza, R. Trends and Factors Related to Smokeless Tobacco Use in the United States. Nicotine Tob. Res. 2016, 18, 1740–1748. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Lipari, R.N.; Van Horn, S.L. Trends in smokeless tobacco use and initiation: 2002 to 2014. In The CBHSQ Report: May 31, 2017; Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration: Rockville, MD, USA, 2017. [Google Scholar]
  17. Al Rifai, M.; Kianoush, S.; Saeed, A.; Krittanawong, C.; Merchant, A.T.; Virani, S.S. Temporal Trends in the Prevalence of Current E-Cigarette and Cigarette Use by Annual Household Income from 2016 to 2018 (from the Behavioral Risk Factor Surveillance System [BRFSS] Survey). Am. J. Cardiol. 2020, 137, 139–140. [Google Scholar] [CrossRef]
  18. Bandi, P.; Cahn, Z.; Goding Sauer, A.; Douglas, C.E.; Drope, J.; Jemal, A.; Fedewa, S.A. Trends in E-Cigarette Use by Age Group and Combustible Cigarette Smoking Histories, U.S. Adults, 2014–2018. Am. J. Prev. Med. 2021, 60, 151–158. [Google Scholar] [CrossRef] [PubMed]
  19. Owusu, D.; Huang, J.; Weaver, S.R.; Pechacek, T.F.; Ashley, D.L.; Nayak, P.; Eriksen, M.P. Patterns and trends of dual use of e-cigarettes and cigarettes among U.S. adults, 2015–2018. Prev. Med. Rep. 2019, 16, 101009. [Google Scholar] [CrossRef]
  20. Kong, G.; Mayer, M.E.; Barrington-Trimis, J.L.; McConnell, R.; Leventhal, A.M.; Krishnan-Sarin, S. Longitudinal associations between use and co-use of cigars and cigarettes: A pooled analysis of three adolescent cohorts. Drug Alcohol Depend. 2019, 201, 45–48. [Google Scholar] [CrossRef]
  21. Macy, J.T.; Li, J.; Xun, P.; Presson, C.C.; Chassin, L. Dual Trajectories of Cigarette Smoking and Smokeless Tobacco Use From Adolescence to Midlife Among Males in a Midwestern US Community Sample. Nicotine Tob. Res. 2016, 18, 186–195. [Google Scholar] [CrossRef]
  22. Sung, H.Y.; Wang, Y.; Yao, T.; Lightwood, J.; Max, W. Polytobacco Use of Cigarettes, Cigars, Chewing Tobacco, and Snuff Among US Adults. Nicotine Tob. Res. 2016, 18, 817–826. [Google Scholar] [CrossRef] [Green Version]
  23. Choi, K.; Inoue-Choi, M.; McNeel, T.S.; Freedman, N.D. Mortality Risks of Dual- and Poly-Tobacco Product Users in the United States. Am. J. Epidemiol. 2019, kwz143. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Rostron, B.L.; Schroeder, M.J.; Ambrose, B.K. Dependence symptoms and cessation intentions among US adult daily cigarette, cigar, and e-cigarette users, 2012–2013. BMC Public Health 2016, 16, 814. [Google Scholar] [CrossRef] [Green Version]
  25. Sung, H.Y.; Wang, Y.; Yao, T.; Lightwood, J.; Max, W. Polytobacco Use and Nicotine Dependence Symptoms Among US Adults, 2012–2014. Nicotine Tob. Res. 2018, 20, S88–S98. [Google Scholar] [CrossRef] [PubMed]
  26. Blewett, L.A.; Drew, J.A.R.; King, M.L.; Williams, K.C.W. IPUMS Health Surveys: National Health Interview Survey, Version 6.4 [Dataset]; IPUMS: Minneapolis, MN, USA, 2019. [Google Scholar] [CrossRef]
  27. US Census Bureau; National Cancer Institute; and Food and Drug Administration. Current Population Survey, May 2015: Tobacco Use Supplement Technical Documentation. Available online: https://cancercontrol.cancer.gov/sites/default/files/2020-06/cpsmay15.pdf (accessed on 28 November 2021).
  28. US Census Bureau; National Cancer Institute; and Food and Drug Administration. Current Population Survey, May 2019: Tobacco Use Supplement Technical Documentation. Available online: https://www2.census.gov/programs-surveys/cps/techdocs/cpsmay19.pdf (accessed on 28 November 2021).
  29. The Tobacco Use Supplement to the Current Population Survey (TUS-CPS). [Internet]. Available online: http://appliedresearch.cancer.gov/tus-cps/ (accessed on 30 November 2021).
  30. Soulakova, J.; Davis, W.W.; Hartman, A.; Gibson, J. The Impact of Survey and Response Modes on Current Smoking Prevalence Estimates Using TUS-CPS: 1992-2003. Surv. Res. Methods 2009, 3, 123–137. [Google Scholar] [PubMed]
  31. National Center for Health Statistics. Survey Description, National Health Interview Survey, 2015; National Center for Health Statistics: Hyattsville, MD, USA, 2016.
  32. National Center for Health Statistics. Survey Description, National Health Interview Survey, 2016; National Center for Health Statistics: Hyattsville, MD, USA, 2017.
  33. National Center for Health Statistics. Survey Description, National Health Interview Survey, 2017; National Center for Health Statistics: Hyattsville, MD, USA, 2018.
  34. National Center for Health Statistics. Survey Description, National Health Interview Survey, 2018; National Center for Health Statistics: Hyattsville, MD, USA, 2019.
  35. National Center for Health Statistics. Survey Description, National Health Interview Survey, 2019; National Center for Health Statistics: Hyattsville, MD, USA, 2020.
  36. The National Health Interview Survey Data, Questionnaires and Related Documentation. [Internet]. Available online: https://www.cdc.gov/nchs/nhis/data-questionnaires-documentation.htm (accessed on 30 November 2021).
  37. Judkins, D. Fay’s method for variance estimation. J. Off. Stat. 1990, 6, 223–239. [Google Scholar]
  38. Williams, R.L. Taylor Series Linearization (TSL). In Encyclopedia of Survey Research Methods; Lavrakas, P.J., Ed.; Sage Publications Inc.: Thousand Oaks, CA, USA, 2008. [Google Scholar]
  39. StataCorp. Stata Statistical Software: Release 16; StataCorp LLC: College Station, TX, USA, 2019. [Google Scholar]
  40. Merianos, A.L.; Mancuso, T.F.; Gordon, J.S.; Wood, K.J.; Cimperman, K.A.; Mahabee-Gittens, E.M. Dual- and Polytobacco/Nicotine Product Use Trends in a National Sample of High School Students. Am. J. Health Promot. 2018, 32, 1280–1290. [Google Scholar] [CrossRef] [PubMed]
  41. Osman, A.; Kowitt, S.D.; Ranney, L.M.; Heck, C.; Goldstein, A.O. Trends and Racial Disparities in Mono, Dual, and Poly Use of Tobacco Products Among Youth. Nicotine Tob. Res. 2018, 20, S22–S30. [Google Scholar] [CrossRef]
  42. Malas, M.; van der Tempel, J.; Schwartz, R.; Minichiello, A.; Lightfoot, C.; Noormohamed, A.; Andrews, J.; Zawertailo, L.; Ferrence, R. Electronic Cigarettes for Smoking Cessation: A Systematic Review. Nicotine Tob. Res. 2016, 18, 1926–1936. [Google Scholar] [CrossRef]
  43. Loukas, A.; Paddock, E.M.; Li, X.; Harrell, M.B.; Pasch, K.E.; Perry, C.L. Electronic Nicotine Delivery Systems Marketing and Initiation Among Youth and Young Adults. Pediatrics 2019, 144, e20183601. [Google Scholar] [CrossRef]
  44. Dai, H.; Leventhal, A.M. Prevalence of e-Cigarette Use Among Adults in the United States, 2014–2018. JAMA 2019, 322, 1824–1827. [Google Scholar] [CrossRef] [Green Version]
  45. Brouwer, A.F.; Jeon, J.; Hirschtick, J.L.; Jimenez-Mendoza, E.; Mistry, R.; Bondarenko, I.V.; Land, S.R.; Holford, T.R.; Levy, D.T.; Taylor, J.M.G.; et al. Transitions between cigarette, ENDS and dual use in adults in the PATH study (waves 1-4): Multistate transition modelling accounting for complex survey design. Tob. Control 2020, 0, 1–8. [Google Scholar] [CrossRef] [PubMed]
Table 1. Population prevalence of exclusive, dual and polytobacco use among U.S. adults from 2014/2015 to 2018/2019.
Table 1. Population prevalence of exclusive, dual and polytobacco use among U.S. adults from 2014/2015 to 2018/2019.
Tobacco Product UseTUS-CPSNHIS
2014/20152018/2019p-Value20152019p-Value
%95% CI%95% CI%95% CI%95% CI
 Any tobacco product17.2717.09–17.4615.2515.03–15.47<0.00120.3319.66–21.0020.8020.10–21.400.367
 Exclusive cigarette10.8910.75–11.039.439.25–9.60<0.00111.3610.86–11.8610.8510.38–11.330.143
 Exclusive ENDS0.680.64–0.721.221.16–1.29<0.0011.261.09–1.432.352.14–2.58<0.001
 Exclusive OC1.651.58–1.721.551.48–1.620.0642.332.07–2.582.232.02–2.460.552
 Exclusive SLT1.171.11–1.221.030.97–1.090.0011.411.19–1.621.571.40–1.770.246
 Dual cigarettes + ENDS1.331.27–1.390.740.60–0.79<0.0011.621.42–1.811.251.10–1.430.005
 Dual cigarettes + OC0.790.74–0.840.600.56–0.65<0.0011.090.94–1.241.100.97–1.240.950
 Dual cigarettes + SLT0.220.20–0.240.180.16–0.20<0.0010.370.26–0.470.300.23–0.380.287
 Poly with cigarettes0.310.28–0.340.210.18–0.25<0.0010.530.41–0.640.480.38–0.600.554
 Dual/Poly w/o cigarettes0.250.25–0.270.290.26–0.330.0590.370.27–0.470.630.51–0.770.002
TUS-CPS: Tobacco Use Supplement to the Current Population Survey; NHIS: National Health Interview Survey; ENDS: electronic nicotine delivery systems; OC: other combustible tobacco products; SLT: smokeless tobacco products. Bolded text indicates statistical significance (p < 0.05).
Table 2. Population prevalence of any and exclusive tobacco use among U.S. adults from 2014/2015 to 2018/2019 by age group.
Table 2. Population prevalence of any and exclusive tobacco use among U.S. adults from 2014/2015 to 2018/2019 by age group.
Tobacco Product UseTUS-CPSNHIS
2014/20152018/2019p-Value20152019p-Value
%95% CI%95% CI%95% CI%95% CI
 Any tobacco product
  18–2418.5317.85–19.2313.8613.11–14.65<0.001  21.4719.40–23.6918.1316.25–20.170.024
  25–3420.5220.02–21.0317.5517.05–18.07<0.001  24.4022.78–26.1125.8524.28–27.480.218
  35–5419.1418.83–19.4517.0416.70–17.38<0.00123.3722.20–24.5824.5423.43–25.680.162
  55+13.3613.11–13.6213.0212.73–13.310.05315.0714.25–15.9315.9415.19–16.720.135
 Exclusive cigarette
  18–249.128.57–9.715.214.75–5.72<0.0018.437.10–9.994.513.66–5.56<0.001
  25–3412.2411.85–12.659.559.18–9.93<0.00113.1512.07–14.3011.9110.78–13.130.133
  35–5412.5412.29–12.8111.1210.81–11.45<0.00113.5512.63–14.5313.0912.22–14.010.488
  55+9.259.04–9.479.269.03–9.500.9329.448.78–10.1410.419.79–11.060.041
 Exclusive ENDS
  18–241.120.93–1.343.292.92–3.70<0.0012.391.73–3.305.464.47–6.66<0.001
  25–340.910.80–1.031.801.62–1.99<0.0011.561.19–2.053.572.97–4.28<0.001
  35–540.710.65–0.790.980.88–1.09<0.0011.351.10–1.662.372.05–2.75<0.001
  55+0.370.32–0.410.480.43–0.540.0020.640.48–0.850.800.65–0.980.201
 Exclusive OC
  18–242.552.27–2.871.581.31–1.89<0.001  4.073.20–5.171.851.28–2.65<0.001
  25–342.182.01–2.372.151.95–2.370.8193.022.41–3.782.622.00–3.410.418
  35–541.351.26–1.451.511.39–1.640.0482.061.66–2.552.762.37–3.210.023
  55+1.341.25–1.431.281.20–1.370.3791.641.36–1.981.701.47–1.980.766
 Exclusive SLT
  18–241.171.00–1.360.910.74–1.120.0691.490.98–2.251.140.69–1.900.423
  25–341.261.13–1.411.121.00–1.270.1421.541.15–2.061.731.30–2.310.568
  35–541.531.44–1.631.301.21–1.410.0011.711.38–2.132.101.79–2.450.131
  55+0.760.70–0.820.780.72–0.860.5841.020.76–1.381.180.97–1.440.413
TUS-CPS: Tobacco Use Supplement to the Current Population Survey; NHIS: National Health Interview Survey; ENDS: electronic nicotine delivery systems; OC: other combustible tobacco products; SLT: smokeless tobacco products. Bolded text indicates statistical significance (p < 0.05).
Table 3. Population prevalence of dual and polytobacco use among U.S. adults from 2014/2015 to 2018/2019 by age group.
Table 3. Population prevalence of dual and polytobacco use among U.S. adults from 2014/2015 to 2018/2019 by age group.
Tobacco Product UseTUS-CPSNHIS
2014/20152018/2019p-Value20152019p-Value
%95% CI%95% CI%95% CI%95% CI
 Dual cigarettes + ENDS
  18–241.301.10–1.530.810.63–1.030.0021.531.10–2.141.350.87–2.080.636
  25–341.681.53–1.841.161.03–1.30<0.0011.481.10–1.982.191.74–2.740.035
  35–541.581.49–1.680.800.72–0.89<0.0012.261.92–2.651.601.34–1.920.006
  55+0.910.84–0.980.460.40–0.52<0.0011.110.88–1.390.480.38–0.62<0.001
 Dual cigarettes + OC
  18–241.361.15–1.600.440.33–0.59<0.0010.850.52–1.401.120.72–1.710.419
  25–341.050.92–1.200.720.63–0.84<0.0011.611.22–2.131.160.83–1.610.131
  35–540.760.69–0.830.680.62–0.760.1851.240.99–1.561.241.01–1.510.992
  55+0.470.41–0.530.520.47–0.580.2090.780.59–1.020.940.78–1.140.242
 Dual cigarettes + SLT
  18–240.370.29–0.480.230.14–0.370.0940.840.42–1.670.190.07–0.530.037
  25–340.370.31–0.430.280.22–0.360.0600.570.34–0.960.480.31–0.740.626
  35–540.250.21–0.290.220.18–0.270.3130.310.21–0.480.420.29–0.600.307
  55+0.070.05–0.090.070.05–0.090.8440.150.08–0.290.140.09–0.230.871
 Poly with cigarettes
  18–240.800.65–1.000.590.43–0.800.1201.040.64–1.710.850.47–1.540.595
  25–340.480.40–0.580.340.26–0.440.0191.030.68–1.541.030.72–1.451.000
  35–540.250.21–0.290.190.16–0.230.0220.450.32–0.640.480.35–0.660.794
  55+0.11 0.09–0.130.050.04–0.070.0010.180.10–0.300.100.06–0.200.231
 Dual/Poly w/o cigarettes
  18–240.740.61–0.890.810.63–1.040.5880.810.48–1.361.661.11–2.460.033
  25–340.350.29–0.430.430.35–0.540.1380.450.27–0.771.180.86–1.600.001
  35–540.160.13–0.200.230.18–0.280.0230.440.28–0.690.480.33–0.680.775
  55+0.100.07–0.130.100.08–0.130.6230.120.06–0.240.180.10–0.300.347
TUS-CPS: Tobacco Use Supplement to the Current Population Survey; NHIS: National Health Interview Survey; ENDS: electronic nicotine delivery systems; OC: other combustible tobacco products; SLT: smokeless tobacco products. Bolded text indicates statistical significance (p < 0.05).
Table 4. Population prevalence of any and exclusive tobacco use among U.S. adults from 2014/2015 to 2018/2019 by sex.
Table 4. Population prevalence of any and exclusive tobacco use among U.S. adults from 2014/2015 to 2018/2019 by sex.
Tobacco Product UseTUS-CPSNHIS
2014/20152018/2019p-Value20152019p-Value
%95% CI%95% CI%95% CI%95% CI
 Any tobacco product
  Female13.2112.99–13.4411.4711.23–11.72<0.00115.3814.65–16.1315.6914.95–16.460.560
  Male21.6521.38–19.3119.3118.96–19.67<0.00125.6424.56–26.7526.1525.24–27.090.481
 Exclusive cigarette
  Female10.119.92–10.308.768.55–8.97<0.00111.2010.58–11.8510.7610.16–11.390.325
  Male11.7311.52–11.9410.159.89–10.41<0.00111.5310.84–12.2610.9410.29–11.620.233
 Exclusive ENDS
  Female0.540.50–0.591.020.94–1.10<0.0010.890.72–1.111.931.66–2.23<0.001
  Male0.820.76–0.891.451.35–1.56<0.0011.661.40–1.962.812.49–3.16<0.001
 Exclusive OC
  Female0.510.46–0.570.510.46–0.570.9320.840.65–1.090.690.53–0.880.253
  Male2.882.75–2.812.672.53–2.810.0343.923.49–4.403.873.47–4.320.880
 Exclusive SLT
  Female0.090.08–0.110.080.07–0.100.5110.130.09–0.210.170.10–0.270.538
  Male2.322.22–2.442.051.93–2.180.0012.772.37–3.243.072.73–3.470.298
TUS-CPS: Tobacco Use Supplement to the Current Population Survey; NHIS: National Health Interview Survey; ENDS: electronic nicotine delivery systems; OC: other combustible tobacco products; SLT: smokeless tobacco products. Bolded text indicates statistical significance (p < 0.05).
Table 5. Population prevalence of dual and polytobacco use among U.S. adults from 2014/2015 to 2018/2019 by sex.
Table 5. Population prevalence of dual and polytobacco use among U.S. adults from 2014/2015 to 2018/2019 by sex.
Tobacco Product UseTUS-CPSNHIS
2014/20152018/2019p-Value20152019p-Value
%95% CI%95% CI%95% CI%95% CI
 Dual cigarettes + ENDS
  Female1.401.32–1.490.670.62–0.73<0.0011.511.29–1.781.231.04–1.460.085
  Male1.241.16–1.320.810.74–0.89<0.0011.731.46–2.041.271.05–1.540.018
 Dual cigarettes + OC
  Female0.340.30–0.380.280.24–0.320.0320.500.37–0.660.530.42–0.670.739
  Male1.271.18–1.360.950.87–1.03<0.0011.721.47–2.021.701.46–1.980.901
 Dual cigarettes + SLT
  Female0.030.01–0.040.020.00–0.030.1690.020.01–0.060.050.02–0.100.354
  Male0.430.39–0.480.350.30–0.400.0090.730.55–0.980.570.44–0.730.201
 Poly with cigarettes
  Female0.140.11–0.170.070.05–0.10<0.0010.180.10–0.320.160.10–0.260.731
  Male0.500.45–0.560.370.32–0.430.0030.900.71–1.140.820.64–1.060.618
 Dual/Poly w/o cigarettes
  Female0.050.04–0.070.080.06–0.110.0670.090.05–0.170.190.11–0.310.075
  Male0.460.41–0.510.520.45–0.590.1620.680.51–0.911.100.88–1.360.008
TUS-CPS: Tobacco Use Supplement to the Current Population Survey; NHIS: National Health Interview Survey; ENDS: electronic nicotine delivery systems; OC: other combustible tobacco products; SLT: smokeless tobacco products. Bolded text indicates statistical significance (p < 0.05).
Table 6. Population prevalence of any and exclusive tobacco use among U.S. adults from 2014/2015 to 2018/2019 by race/ethnicity.
Table 6. Population prevalence of any and exclusive tobacco use among U.S. adults from 2014/2015 to 2018/2019 by race/ethnicity.
Tobacco Product UseTUS-CPSNHIS
2014/20152018/2019p-Value20152019p-Value
%95% CI%95% CI%95% CI%95% CI
 Any tobacco product
  Hispanic10.8710.42–11.339.549.06–10.05<0.00113.0311.88–14.2813.1411.91–14.460.909
  NH White19.3919.15–19.6417.2416.94–17.54<0.00122.8121.91–23.7423.2922.52–24.070.433
  NH Black17.0616.41–17.7215.5614.93–16.220.00121.2019.46–23.0520.7019.02–22.490.691
  Another race/ethnicity12.8412.25–13.4611.3210.76–11.910.00111.7810.12–13.6616.3114.39–18.440.001
 Exclusive cigarette
  Hispanic7.537.16–7.906.235.85–6.63<0.0018.507.57–9.526.916.03–7.900.021
  NH White11.7811.60–11.9810.3410.11–10.56<0.00112.2711.61–12.9511.8611.29–12.450.367
  NH Black12.0711.52–12.6410.7410.19–11.320.00112.7711.51–14.1412.3410.98–13.830.662
  Another race/ethnicity8.437.95–8.947.166.67–7.670.0016.845.67–8.248.717.25–10.430.072
 Exclusive ENDS
  Hispanic0.430.34–0.540.750.62–0.91<0.0010.950.63–1.441.721.32–2.240.012
  NH White0.820.76–0.881.521.44–1.63<0.0011.501.29–1.742.632.37–2.92<0.001
  NH Black0.330.25–0.450.440.33–0.600.1680.570.36–0.901.631.12–2.350.002
  Another race/ethnicity0.520.41–0.670.980.80–1.21<0.0010.900.49–1.652.411.67–3.450.004
 Exclusive OC
  Hispanic1.070.92–1.241.100.93–1.300.8071.721.30–2.282.161.55–3.010.319
  NH White1.811.73–1.891.591.50–1.680.0012.392.08–2.742.201.96–2.470.358
  NH Black2.041.81–2.302.392.11–2.700.1003.362.61–4.323.232.57–4.040.811
  Another race/ethnicity0.930.74–1.170.960.76–1.210.8671.340.85–2.111.230.81–1.850.785
 Exclusive SLT
  Hispanic0.220.16–0.300.150.10–0.210.0790.260.12–0.530.190.10–0.350.526
  NH White1.601.53–1.681.471.38–1.570.0331.971.67–2.312.201.95–2.480.260
  NH Black0.400.31–0.490.280.20–0.380.0580.460.31–0.700.390.24–0.630.589
  Another race/ethnicity0.580.46–0.730.540.41–0.710.7000.290.13–0.671.120.65–1.930.013
TUS–CPS: Tobacco Use Supplement to the Current Population Survey; NHIS: National Health Interview Survey; ENDS: electronic nicotine delivery systems; OC: other combustible tobacco products; SLT: smokeless tobacco products. Bolded text indicates statistical significance (p < 0.05).
Table 7. Population prevalence of dual and polytobacco use among U.S. adults from 2014/2015 to 2018/2019 by race/ethnicity.
Table 7. Population prevalence of dual and polytobacco use among U.S. adults from 2014/2015 to 2018/2019 by race/ethnicity.
Tobacco Product UseTUS-CPSNHIS
2014/20152018/2019p-Value20152019p-Value
%95% CI%95% CI%95% CI%95% CI
 Dual cigarettes + ENDS
  Hispanic1.211.02–1.430.650.50–0.84<0.0010.690.49–0.980.590.37–0.930.570
  NH White0.520.43–0.640.430.33–0.560.2111.931.67–2.231.491.27–1.730.015
  NH Black1.651.57–1.730.900.84–0.97<0.0011.280.87–1.861.040.67–1.630.502
  Another race/ethnicity0.660.55–0.800.350.25–0.490.0011.340.81–2.221.070.64–1.790.540
 Dual cigarettes + OC
  Hispanic0.560.43–0.740.500.39–0.640.5450.490.33–0.720.900.62–1.300.036
  NH White0.710.59–0.860.440.35–0.560.0041.080.91–1.271.140.98–1.330.610
  NH Black0.760.70–0.820.580.52–0.63<0.0012.371.85–3.031.260.88–1.790.003
  Another race/ethnicity1.201.02–1.401.030.87–1.220.2020.390.20–0.730.930.60–1.430.024
 Dual cigarettes + SLT
  Hispanic0.140.10–0.210.060.03–0.100.0200.040.01–0.130.130.05–0.350.225
  NH White0.040.02–0.080.050.03–0.100.5560.530.39–0.710.420.33–0.540.285
  NH Black0.300.27–0.340.250.22–0.290.0290.090.03–0.270.040.01–0.150.389
  Another race/ethnicity0.060.03–0.100.030.01–0.080.3160.050.02–0.150.040.01–0.150.738
 Poly with cigarettes
  Hispanic0.310.21–0.450.170.09–0.290.0980.240.12–0.510.270.13–0.530.856
  NH White0.200.14–0.290.190.13–0.300.9080.660.51–0.840.600.46–0.780.600
  NH Black0.360.33–0.400.240.21–0.29<0.0010.160.08–0.310.200.10–0.420.654
  Another race/ethnicity0.170.12–0.240.110.06–0.200.2120.580.17–1.920.400.20–0.830.651
 Dual/Poly w/o cigarettes
  Hispanic0.160.09–0.270.300.21–0.430.0450.140.05–0.350.270.14–0.550.242
  NH White0.160.10–0.230.190.14–0.270.4210.500.38–0.670.750.60–0.940.027
  NH Black0.300.26–0.340.330.29–0.380.2820.150.06–0.370.580.30–1.110.035
  Another race/ethnicity0.140.09–0.210.190.12–0.300.2980.050.01–0.180.400.18–0.890.033
TUS-CPS: Tobacco Use Supplement to the Current Population Survey; NHIS: National Health Interview Survey; ENDS: electronic nicotine delivery systems; OC: other combustible tobacco products; SLT: smokeless tobacco products. Bolded text indicates statistical significance (p < 0.05).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mattingly, D.T.; Zavala-Arciniega, L.; Hirschtick, J.L.; Meza, R.; Levy, D.T.; Fleischer, N.L. Trends in Exclusive, Dual and Polytobacco Use among U.S. Adults, 2014–2019: Results from Two Nationally Representative Surveys. Int. J. Environ. Res. Public Health 2021, 18, 13092. https://doi.org/10.3390/ijerph182413092

AMA Style

Mattingly DT, Zavala-Arciniega L, Hirschtick JL, Meza R, Levy DT, Fleischer NL. Trends in Exclusive, Dual and Polytobacco Use among U.S. Adults, 2014–2019: Results from Two Nationally Representative Surveys. International Journal of Environmental Research and Public Health. 2021; 18(24):13092. https://doi.org/10.3390/ijerph182413092

Chicago/Turabian Style

Mattingly, Delvon T., Luis Zavala-Arciniega, Jana L. Hirschtick, Rafael Meza, David T. Levy, and Nancy L. Fleischer. 2021. "Trends in Exclusive, Dual and Polytobacco Use among U.S. Adults, 2014–2019: Results from Two Nationally Representative Surveys" International Journal of Environmental Research and Public Health 18, no. 24: 13092. https://doi.org/10.3390/ijerph182413092

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop